These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22717269)

  • 1. Pharmacokinetics of the etonogestrel contraceptive implant in obese women.
    Mornar S; Chan LN; Mistretta S; Neustadt A; Martins S; Gilliam M
    Am J Obstet Gynecol; 2012 Aug; 207(2):110.e1-6. PubMed ID: 22717269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between patient characteristics and serum etonogestrel concentrations in contraceptive implant users.
    Lazorwitz A; Aquilante CL; Sheeder J; Guiahi M; Teal S
    Contraception; 2019 Jul; 100(1):37-41. PubMed ID: 30980827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of plasma etonogestrel concentrations sampled from the contralateral-to-implant and ipsilateral-to-implant arms of contraceptive implant users.
    Gertz AM; Bishop IJ; Simon B; Lechiile K; Badubi O; Mussa A; Westhoff CL; Morroni C
    Contraception; 2020 Dec; 102(6):403-405. PubMed ID: 32858051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma concentrations of etonogestrel in women using oral desogestrel before and after Roux-en-Y gastric bypass surgery: a pharmacokinetic study.
    Ginstman C; Frisk J; Carlsson B; Ärlemalm A; Hägg S; Brynhildsen J
    BJOG; 2019 Mar; 126(4):486-492. PubMed ID: 30347490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of etonogestrel released from the contraceptive implant Implanon.
    Wenzl R; van Beek A; Schnabel P; Huber J
    Contraception; 1998 Nov; 58(5):283-8. PubMed ID: 9883383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and ovarian suppression during use of a contraceptive vaginal ring in normal-weight and obese women.
    Westhoff CL; Torgal AH; Mayeda ER; Petrie K; Thomas T; Dragoman M; Cremers S
    Am J Obstet Gynecol; 2012 Jul; 207(1):39.e1-6. PubMed ID: 22727346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of carbamazepine on etonogestrel concentrations in contraceptive implant users.
    Lazorwitz A; Davis A; Swartz M; Guiahi M
    Contraception; 2017 Jun; 95(6):571-577. PubMed ID: 28288788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged use of the etonogestrel implant and levonorgestrel intrauterine device: 2 years beyond Food and Drug Administration-approved duration.
    McNicholas C; Swor E; Wan L; Peipert JF
    Am J Obstet Gynecol; 2017 Jun; 216(6):586.e1-586.e6. PubMed ID: 28147241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variability in repeat serum etonogestrel concentrations among contraceptive implant users during the steady-release pharmacokinetic period.
    Lazorwitz A; Sheeder J; Teal S
    Contraception; 2022 Apr; 108():65-68. PubMed ID: 34973207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilot study of a novel, alternative subdermal scapular insertion site for the etonogestrel contraceptive implant.
    Clure C; Sheeder J; Lazorwitz A
    Contraception; 2024 Jul; 135():110442. PubMed ID: 38552822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postpartum weight loss in overweight and obese women using the etonogestrel subdermal implant: a pilot study.
    Griffin L; Hammond C; Liu D; Rademaker AW; Kiley J
    Contraception; 2017 Jun; 95(6):564-570. PubMed ID: 28238839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etonorgestrel concentrations in morbidly obese women following Roux-en-Y gastric bypass surgery: three case reports.
    Ciangura C; Corigliano N; Basdevant A; Mouly S; Declèves X; Touraine P; Lloret-Linares C
    Contraception; 2011 Dec; 84(6):649-51. PubMed ID: 22078197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An exploratory study on the association of lifestyle factors with serum etonogestrel concentrations among contraceptive implant users.
    Lazorwitz A; Sheeder J; Teal S
    Eur J Contracept Reprod Health Care; 2021 Aug; 26(4):323-325. PubMed ID: 33596152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weight Gain Patterns in Adolescent and Young Adult Women With the Etonogestrel Implant: Comparison by Weight Category.
    Batt CE; Sheeder J; Love-Osborne K
    J Adolesc Health; 2021 Nov; 69(5):815-823. PubMed ID: 34154904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic bioequivalence, safety and acceptability of Ornibel
    Algorta J; Diaz M; de Benito R; Lefebvre M; Sicard E; Furtado M; Regidor PA; Ronchi C
    Eur J Contracept Reprod Health Care; 2017 Dec; 22(6):429-438. PubMed ID: 29336615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etonogestrel concentrations among contraceptive implant users in Botswana using and not using dolutegravir-based antiretroviral therapy.
    Bishop IJ; Gertz AM; Simon B; Tawe L; Lechiile K; Liu S; Teodoro N; Mussa A; Avalos A; Malima S; Maotwe T; Mokganya L; Westhoff CL; Morroni C
    Contraception; 2020 Sep; 102(3):174-179. PubMed ID: 32387328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioequivalence and x-ray visibility of a radiopaque etonogestrel implant versus a non-radiopaque implant: a 3-year, randomized, double-blind study.
    Schnabel P; Merki-Feld GS; Malvy A; Duijkers I; Mommers E; van den Heuvel MW
    Clin Drug Investig; 2012 Jun; 32(6):413-22. PubMed ID: 22540269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contraceptive failure rates of etonogestrel subdermal implants in overweight and obese women.
    Xu H; Wade JA; Peipert JF; Zhao Q; Madden T; Secura GM
    Obstet Gynecol; 2012 Jul; 120(1):21-6. PubMed ID: 22678035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contraceptive vaginal ring effectiveness is maintained during 6 weeks of use: a prospective study of normal BMI and obese women.
    Dragoman M; Petrie K; Torgal A; Thomas T; Cremers S; Westhoff CL
    Contraception; 2013 Apr; 87(4):432-6. PubMed ID: 23312933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immediate versus delayed insertion of an etonogestrel releasing implant at medical abortion-a randomized controlled equivalence trial.
    Hognert H; Kopp Kallner H; Cameron S; Nyrelli C; Jawad I; Heller R; Aronsson A; Lindh I; Benson L; Gemzell-Danielsson K
    Hum Reprod; 2016 Nov; 31(11):2484-2490. PubMed ID: 27664217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.